ISOLATOR TECHNOLOGY MANUFACTURING



Similar documents
Case Study Neubau einer Parenteralia Fabrik 3. GMP-Forum, Kirchzarten 28. September 2012, Basel. Philip Schneider, F.

Environmental Monitoring of Clean Rooms

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

The use of risk assessment tools for microbiological assessment of cleanroom environments. by Tim Sandle

Cleanroom. For. Sterile Manufacturing Facilities

Steam Sterilization and the 2007 Revision of PDA Technical Report 1

WHITE PAPER April 18, 2016

Particle Monitoring Requirements in Pharmaceutical Cleanrooms

All Processes Dr. Paul Ruffieux Consultant

EU GMP Annex 1 Update 2008: Airborne Particle Counting

Environmental Monitoring

International Standard ISO 14644

CLEAN ROOM MONITORING REGULATORY STANDARDS

Regulations Concerning

Environmental Monitoring

Risk-Based Environmental Monitoring. Marsha Stabler Hardiman Senior Consultant Concordia ValSource Wednesday September 17, 2014 FDA/PQRI

Qualification of Cleanrooms and Environmental Monitoring - Practical Approaches in Europe

How To Control A Medical Device With A Pc System

Basic Requirements For Aseptic Manufacturing Of Sterile Medicinal Products A Comparison Between Europe And USA

Cleaning. By the end of this chapter, you will be able to: Introduction. Definitions. Chapter 9

Principles. of Pharmaceutical Facility Design. Full Time Part Time Online.

Raleigh, NC May 12 th & 13 th Meeting The New ISO Cleanroom Standards And Changing EU Guidance How Will You Comply?

Design, Construction, Commission, and Qualification of Critical Utility Systems: Part III

Guidance on safe use of Autoclaves

ENVIRONMENTAL MONITORING

Cleaning validation of cleanrooms and preparation equipments

VALIDATION OF CLEAN ROOMS FOR ASEPTIC MANUFACTURING. F.R.Smal Pharmaceutical Director ICCE ICCE a member of SNC-Lavalin Group

Design, Operation and Management of GTP/GMP Cell Engineering Facilities

Understanding USP 797

Particle Counting and Environmental Monitoring In Pharmaceutical / Life Sciences

Manufacturing. Environmental Monitoring Particle Counts Are Easy B IOP ROCESSTECHNICAL. Scott E. Mackler

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Top 10 considerations when validating an autoclave

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Qualification of an Environmental Monitoring Program

VALIDATION OF ASEPTIC PROCESSES

Hazardous Drug. Cleanroom. Standards

CLASSIFICATION OF CLEANROOMS

German engineering under high pressure

Case Study: Successful Decontamination of an HVAC System s Ductwork Using Chlorine Dioxide Gas

FDA and the Compounding Pharmacy

ENVIRONMENTAL MONITORING / TESTING TO CONFORM WITH ISO14644 & TGA GMP REQUIREMENTS

MOHD NASRUL MOHAMAD NOOR

Sterilization methods and equipment Lab 1-2

White Paper. Life Sciences Industry Solution Blueprint for Environmental Monitoring Systems (EMS) ISPE Guidance and Best Practices.

Barrier and isolation systems

Cleaning and Contamination Control

Particle testing in cleanroom high-pressure gas lines to ISO made easy with the MET ONE 3400 gas calibrations

Contamination Control and Environmental Monitoring Systems

Decontamination and Waste Management

Environmental Monitoring Risk Assessment

USP <797> Cleanroom Design and Environmental Monitoring. Andrew King, USP <797> Specialist CETA Member RCCP-SC

or

Risk Based Environmental Monitoring (EM) and EM Data Management and Trending

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Air Shower Biosafety Changing Station with Pass-Through Box Pass-Through Box Automatic atomizer for no-contact hand disinfection

Air and Water Balancing - Sound and Vibration Testing - Cleanroom Services - Building Commissioning Building Envelope Testing Thermal Imaging

Procedures for the Effective Use of Biological Safety Cabinets

Cleaning and Disinfection Agenda. 1. Cleanroom Classification. Cleanroom Classification. What does contamination mean? Types of contamination

TSI BIOTRAK REAL-TIME VIABLE PARTICLE COUNTER FACILITY MONITORING SYSTEMS

Everything you want to know about USP 797

How to Estimate the Cost of a. Laboratory Renovation. Candidate Number:

Laminar Flow Cabinets

Pharmagraph. GMP/GLP Monitoring System

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

WIBObarrier OCS - Open Containment Systems WIBObarrier CCS - Closed Containment Systems

Validation and Management of Heat Sterilization (Autoclave and Dry Heat Oven)

Guide to in situ leak testing of HEPA filter configurations that cannot be conventionally scan tested

ENVIRONMENTAL TESTING & MONITORING: Deciphering Compliance Requirements for Pharmaceutical and Medical Device Manufacturers A WHITE PAPER

FILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS


HEPA Filters for Pharma Applications Cleanrooms & Safety Applications. Gordon Farquharson June 2012

GEA Niro Pharmaceutical GMP Spray Drying facility. Spray drying process development and contract manufacturing. engineering for a better world

AMENDED January 27, 2015

Workflow System for Paperless Air Monitoring Powered by MODA. Presented by

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

EH&S. Sheet. Fact. Safe and Effective Use of Autoclaves. What are autoclaves? Factors for effective sterilization. Dry heat cycle - when to use

Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

USP Guidances on Environmental Control including related USP, FDA, EMEA & PDA Activities. James Agalloco Agalloco & Associates

Packaging Validation according to ISO 11607

Media fills Periodic performance qualification (Re-Validation)

Terminal Sterilization. vs. Aseptic Processing

Practical Series Seminars and Workshops INTENSIVE TRAINING IN ENVIRONMENTAL MONITORING, DISINFECTANT QUALIFICATION AND CLEANROOM CONTAMINATION CONTROL

Sterile Cleanroom Management

Sterile operation scenarios at GSK-Parma

Laboratory & Scientific Line. Bulk Steam Sterilizers. Since

On-Site GMP Training GMP COMPLIANCE TECHNICAL

Validation of process gas systems

Liquid II Cell Culture Media Manufacturing Plant. Overview Facilities Water for Injection Sterile Environment Media Handling Cleanroom Interior

Class II Type B2 Laminar Flow Biological Safety Cabinets at Ordering Criteria for the National Institutes of Health

Qualifying Visual Inspectors - The benchmarking process. Markus Lankers, PhD Rap.ID Particle Systems GmbH December 2014

BSL3 and BSL4 Autoclaves. Laboratory Line

Monitoring. Compliant and Reasonable. 5-6 May 2015, Berlin, Germany

Aseptic preparations, including TPN, for a limited number of patients

*XLGHIRULQVSHFWLRQRI PDQXIDFWXUHUVRIELRORJLFDOSURGXFWV

BEHAVIOUR EXPERIENCE MEDIA FILL QUALIFICATION TRAINING MONITORING GOWNING PERSONAL ATTRIBUTES QUALIFICATION

Risk Assessment: Biosafety Cabinet

Downstream processing areas of pharmaceutical

Transcription:

ISOLATOR TECHNOLOGY MANUFACTURING Design Qualification Experience Complimentary WEBINAR Wednesday, December 12, 2007 This webinar presents the methods used at Baxter s Halle, Germany facility for the design and validation/qualification of isolators used for the aseptic production of sterile drug products. Featured Speakers: Frank Generotzky Corinna Schneider

Speakers Frank Generotzky Director of Technology and Engineering Mr. Frank Generotzky is recognized as an expert in the field of aseptic manufacturing of parenteral products, and is a frequent presenter at several European Conferences and ISPE Meetings for Sterile Drug Manufacturing. He earned his Diploma for Pharmaceutical Engineering from the University of Applied Science Lippe / Höxter in Germany. Since 1996 Frank has designed and installed several production-lines in standard Cleanroom Technology as well as in Isolator Technology at Baxter s facility in Halle, Germany. Starting in 2001 Frank headed the production department for sterile cytotoxic drugs (liquid, powders and lyophilisates). In his present role, Frank is responsible for the strategic development of Pharmaceutical Technology in Halle. He is leading a team of 13 engineers, who design, plan and realize the investment projects in Halle according to customer and market requirements. Corinna Schneider QA Specialist GMP Compliance Ms. Corinna Schneider, is recognized as an expert in the field of sterile drug products produced by aseptic processing. She developed and implemented a complex VHP sterilization process for isolators and equipment parts in Halle/Germany and presented this method at pharmaceutical conferences and workshops in Europe and in the US. She trained local regulatory inspectors in VHP cycle development and presented her concept several times to the FDA. Ms. Schneider earned her Diploma for Pharmaceutical Engineering from the University of Applied Science Lippe / Höxter in Germany. From 1995 to 2000 she headed the Microbiological Quality Control Lab and focused on environmental monitoring, validation of aseptic processing, and microbial identification. In her current position in Quality Assurance she is responsible for GMP compliance, internal and external auditing, and several compliance projects to improve the effectiveness of the quality management system. 2

Topics Isolator Design Criteria - Different Isolator Applications - Process Development Qualification of critical Design Features - Airflow Investigation Near Mouseholes - Isolator Integrity - VHP Sterilization Isolator Technology versus Conventional Cleanroom 3

Designing Isolators 4

Different Isolator Applications Isolators for compounding and Sterilizable isolators for handling of toxic powder aseptic processing Negative pressure isolators Positive pressure isolators (-50 Pa to -150 Pa) (25 Pa to 100 Pa) ISOLATOR ISOLATOR Isolator for manual sterile Isolators on automatic operations filling machines => Closed Isolators => Open Isolators 5

Different Isolator Applications Requirements on Containment Isolators Generally operated under negative pressure to ensure max. operator safety Typically classified as ISO 7 (Class 10,000 at rest, Grade C) They must not exchange air with the surrounding environment (except through a HEPA filter) Equipped with nitrogen supply if required All materials exiting the isolator must be cleaned or contained They must be cleanable in a reproducible and quantifiable manner; swab-tests and tracer substances should be used during qualification 6

Different Isolator Applications Containment Isolator for Compounding negative pressure of -100 Pa, electronically controlled interlocked isolator door after start of operation visual display indicates permanent status of the isolator radii in the isolator chamber >15 mm, chamber and fittings require gradient of 2 % tightness test before each process glove test prior to manufacturing push push system for exhaust air filters integrated rapid transfer ports (RTP) for loading and discharging without compromising the surrounding 7

Different Isolator Applications Requirements on Isolators for Aseptic Processing They must not exchange air with the surrounding environment except when that air passes though a HEPA filter Typically classified as ISO 5 (Class 100, Grade A) These units are typically operated under positive pressure and are subject to sterilization procedures prior to use They must be sterilized in a reproducible manner (VHP) All materials that enter the isolator must be sterilized and must enter either directly through a decontaminating or sterilizing system or via a rapid transfer port 8

Different Isolator Applications Closed Isolator for Aseptic Operations Closed Box with HEPA filter H14 discontinuously loading and discharging all transfer processes are conducted via aseptic connections (RTP, SIP) Example: Isolator for Aseptic Filling Isolator: - Grade A, (ISO 5) - VHP sterilization - positive pressure (+ 100Pa) Double Door port-system for aseptic discharging of the isolator 9

A Different Isolator Applications Open Isolators for continuous Aseptic Operations D A B A E 4-6Pa. 30Pa. C X B B 20Pa. Vials Inspektionsmaschine 3+4 Inspektionsmaschine 1+2 C E F C F G Aussendekontaminationsanlage Inspektionsmaschine 2560 Inspektionsmaschine 2540 Inspektionsmaschine 2520 Inspektionsmaschine 2500 2400 G D DAR-350 D Andockstation f r Stopfen 2270-10Pa. 10Pa. Hubs ule Stopfen 2295 2390 Ink-Jet H G F E 10

Different Isolator Applications Open Isolators for continuous Aseptic Operations Continuous supply with materials during operation, while maintaining Grad A ISO 5 Unidirectional airflow of 0.45 m/s (+/- 0.1m/s) Safety features: - double wall design - filtration of recirculated air - pneumatic gaskets (controlled and alarmed) - CIP for containment and air ducts - emergency mode including pressure reversal 11

A Different Isolator Applications Open Isolators for continuous aseptic Operations Classifications: Filling: Capping: Support Area: ISO 5 / Grade A ISO 7 / Grade C ISO 8 / Grade D D 4 Pa E A 40 Pa ISO 5 VHP sterilization for ISO 5 / Grade A - stopper bowls included in VHP sterilization - CIP / SIP for filling equipment 4-6Pa. 30Pa. Caps and capping equipment: - no sterilisation - controlled disinfection B B 30 Pa ISO 5 20Pa. Environmental Monitoring: - particles 0.5µm, 5.0µm - viable air monitoring -surfaces (RODAC) - Temp, diff. pressure, relative humidity -10 Pa 0 a- e -10Pa. D C H F 10Pa. G E F G D 10 Pa ISO 7 C Andockstation f r Stopfen 2270 Hubs ule Stopfen 2295 G 12

Different Isolator Applications Example: Design HVAC Isolators should be equipped with independent HVAC systems zur Zentralanlage H13 von Zentralanlage "Safe change" Technikebene begehbar (Tonnendach) Zwischendecke H13 Abluft über Dach "Safe change" U15 U15 Umluft Luftaufbereitung M + P (inkl. VHP-System) Plenum H14 zur Zentralanlage H13 Produktionsraum Klasse D Raum 21.50 U15 U15 U15 CG - Verteiler "Safe change" max. 2 x 1.000 m³/h ( während Belüftung nach VHP - Zyklus ) Überdruck im Isolator 30 Pa 13

Configuration of an Isolator 14

Mock-Up and Risk Analysis Cleaning Changeover Testrun Leak tightness Sanitization Sterilization Set-up before start Manufacturing Process IPC / Monitoring CIP Reinigung Isolatoren und produktb. Teile Abfüllmaschine Justage Initiatoren Handschuhtest Beladen Isolatoren Justierung Kalibrierung Filtertest Integrität Isolator Dichtigkeit SIP Abfüllmaschine (SIP) Isolator (VHP) Abfüllmaschine Ausrüstung IPK Temperatur, Druck Reinigungszeit Rückstände SOP s reproduzierbare Positionierung Beladung Grenzwerte f. Dichtigkeit SOP s Grenzwerte IPK Waage Grenzwert Druckabfall Zeit Temperatur, Druck, Menge, Zeit, Differenzdruck Qualification / Validation Validation of aeptic processing and Cleaning Validation Reinigungseffizienz Validierung Beladung Grenzwert Druckabf. Sterilisation von: - Stopfen - produktberühr. Teile - VHP Isolator Formatbezogene Vorgaben zur Maschineneinstellung Qualifizierung der zul. Dichtigkeit Validierung der VHP Sterilisation und SIP MA Qualifizierung Qualifizierung Reinraums Füllmenge Monitoring (physik. /mikrobiologisch) v (Luft) p (diff.), T (Luft) rel. Feuchte (Luft), 100% Inspektion Qualifizierung der Transfersysteme 15

Process Development Mock-up Study (Model Scale 1:1) - determination of the size; use 1:1 drawings of all machines in the isolator - simulate loading (tools, agar, probes ) - determine positions for particle counting and viable air monitoring - determine ports for validation purpose (t, p, rel. humidity, NIR, filter integrity ) - determine position for gloves carefully - define interfaces for HVAC, media, computer-systems, supplier of filling-machine - use CIP / SIP where ever possible, reduce manual handling Simulation of all operations in the isolator - change of product contacting parts - simulate monitoring - adjustment of sensors or leadings - solve technical problems (jam of vials or stoppers..) 16

Qualification of an Isolator 17

Qualification of critical Design Features Isolators require a high level of qualification and validation with focus on: Airflow Investigation Near Mouseholes Isolator Integrity Vaporised Hydrogen Peroxid (VHP) Sterilization 18

Inspectional Findings: Isolator Qualification (R. Friedmann & J. Agalloco*) Dynamic filling line conditions not evaluated. Filling line was not in operation during smoke studies. Smoke studies did not evaluate the pressure changes caused by introducing a glove into the isolator, or retrieving the glove from the isolator. There was no data documenting isolator airflow parameters, such as air pressurization and velocities, during smoke studies. The acceptability of the lower air pressure limit was not evaluated. * Presentation by R. Friedman & J. Agalloco; Agallaco & Ass., NJ 2004 19

Qualification of Isolator Integrity near Mouseholes PDA TR 34 Appendix B L-R Method In this test a concentration of particles with a mean size of approximately 0.5 µm is generated within 5-10 cm of the isolator opening. Grade A +30 Pa The particle concentration should be in the range of 100,000-1,000,000 per m³. An electronic particle counter calibrated to the 0.5µm particulate size is used to scan the opening from inside the isolator. The particle counts observed on the isolator side of the opening should not be significantly different from the background count at the same location. Grade C +10 Pa In the measuring location (critical region) the number of particles per unit volume should be less than 0.01% of the initial challenge level to assure absence of airborne microbial contamination under routine operational conditions. 20

Isolator Integrity Leak-Testing Pressure Hold Test - positive pressure isolators - Test pressure: operating pressure x 2 - less than 0.5% of the total volume of the isolator per hour is acceptable Pressure Drop Test - negative pressure isolators - Test pressure: -200Pa - max. 50 Pa rise of pressure 6 min is acceptable Gloves (Hypalon 0.8 mm): - Test pressure: 500 Pa after stressing the glove - less than 50 Pa in 4 min - supported by physical / microbial qualifications and trend analysis 21

VHP Sterilization Examples of Inspectional FDA Findings (R. Friedmann & J. Agalloco) Decontamination validation cycle study did not evaluate the actual commercial cycle. Validation runs were conducted at levels which often exceeded the proposed hydrogen peroxide decontamination concentration setpoint of *** mg/l by as much as 30-90%. No actual measurements of concentration of sterilant that circulated within the expansive isolator. Only indirect measurements (e.g., internal VHP 1001 generator results for flow rate and H2O2 mg/l) to monitor VHP concentration. The VHP decontamination studies for the isolator did not provide an adequate challenge of the cycle to determine the weak points of VHP distribution/ penetration (i.e., where air flow is most variable or potentially compromised). * Presentation by R. Friedman & J. Agalloco; Agallaco & Ass., NJ 2004 22

VHP Sterilization Examples of Inspectional FDA Findings (R. Friedmann & J. Agalloco) Many worst-case locations were not evaluated. Some examples: - Between fingers of installed isolator gloves. Four of nineteen filling isolator gloves were evaluated, and only at the outside of the cuff - Occluded surface created by folding the glove into its gauntlet (sleeve) during the VHP cycle - the stopper bowl locations of most concern (e.g., low point in the bowl) VHP study inappropriately applied fraction negative mathematics to the vaporized hydrogen peroxide process. The fraction negative mathematical approach is fundamentally premised on essentially uniform distribution of the sterilant, and use of replicates. * Presentation by R. Friedman & J. Agalloco; Agallaco & Ass., NJ 2004 23

100 % Concentration 24 Conditioning Sterilization relative humidity high low Cycle Phases relative humidity Condensation H 2 O 2 -Concentration 0 % Dehumidification Aeration VHP Sterilization VHP Process H2 O 2 -

VHP Sterilization VHP Cycle Development Sterilization Target: 12-log-Reduction = overkill Process Measurement of Process Parameters Use of Biological Indicators Determination of D-Value 25

VHP Sterilization Process Parameters Temperature Determination of temperature differences in the Isolator Reproducibility of temperature profiles Relative Humidity Development of conditioning phase: Determination of time to reach max. relative humidity Reproducibility of RH-profile VHP-Concentration Development of conditioning phase: Determination of time to reach max. VHP concentration Reproducible run of concentration curve Definition of worst case environmental conditions: low gas concentration at low temperatures in the isolator VHP-Distribution Uniform distribution of VHP with chemical indicators VHP-Flow Unidirectional/turbulent VHP Flow, airflow pattern 26

VHP Sterilization Biological Indicator Type Geobacillus stearothermophilus ATCC 12980, 10 6 spores on stainless steel carrier Locations 5-10 BIs per m 3 Masked locations like fingers or crinkles of gloves or rails for stoppers Documented rationale for each BI location Short cycles for identification of worst case locations => non-sterile BIs 27

VHP Sterilization Biological Indicator No correlation between process parameters and results of BIs! Determination of worst case locations exclusively based on kill-pattern of BIs! 28

VHP Sterilization Determination of D-value log Population 7,0 6,0 5,0 4,0 3,0 2,0 1,0 0,0-1,0-2,0-3,0-4,0-5,0-6,0-7,0 Survival-Kill-Window Filling Isolator Survival Fractional range t [Min.] 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Kill Sterilization Time for a 12-log-Reduction (worst case location): Sterilization Time (worst case) = D worst case -Value x 12 = X min 29

VHP Sterilization Validation of VHP Sterilization Requirements for Starting Validation Completion of all IQ/OQ activities Completion of cycle development Validation 3 runs Worst case = non operating isolator for min of 12h Acceptance Criteria All BIs sterile Defined H 2 O 2 consumption Color change of chemical indicator Room conditions within limits (T, RH) 30

VHP Sterilization Lessons learned Efficiency and reproducibility of VHP sterilization can only be ascertained and verified using a microbiological system Individual D-Value determination is required for each isolator based on the worst case BI location 31

Isolator Technology vs Conventional Cleanroom 32

Isolator Technology vs Conventional Cleanroom Experiences gathered during Manufacturing Quality of the aseptic environment in the Isolator Isolator Technology Cleanroom Technology Result - VHP sterilization acts sporicidal and validation is possible - VHP is effective on all accessible surfaces - Sanitization with Isopropanol / WFI : 70/30 does not act sporicidal, validation is not possible - Spraying of a disinfectant is less effective Sterility can be maintained more reliable in an reduced aseptic environment with a controlled sterilization method => pro Isolator 33

Isolator Technology vs Conventional Cleanroom Experiences Gathered during Manufacturing Quality of the Conventional Cleanroom versus Isolators : Isolator Technology Cleanroom Technology Result - Main source of micro organism excluded: the operators - Process is protected by a solid barrier - Personnel necessary to run the process - Process is protected by aseptic techniques and unidirectional airflow - Conventional cleanroom technology is more sensitive to human failures => pro Isolator 34

Isolator Technology vs Conventional Cleanroom Experiences gathered during Manufacturing Results after 5 years Monitoring Viable Air Monitoring: Exceeded limits in Grade 100 (ISO 5) Isolators: = 0 Exceeded limits in Grade 100 (ISO 5) sterile core area: = 0 Particles (continuous monitoring 0.5µm / 5.0µm): Exceeded limits in Grade 100 (ISO 5) Isolators < 0.001% Exceeded limits in Grade 100 (ISO 5) sterile core area: > 0.01% Glove, Sleeve, Overall Monitoring: Exceeded limits in Grade 100 (ISO 5) Isolators : = 0 Exceeded limits in Grade 100 (ISO 5) sterile core area: > 0.1% Surface Monitoring: Exceeded limits in Grade 100 (ISO 5) Isolators: = 0 Exceeded limits in Grade 100 (ISO 5) sterile core area: > 0.1% 35

Isolator Technology vs Conventional Cleanroom Experiences gathered during Manufacturing Flexibility Isolator Technology Cleanroom Technology Result - inflexible processes - poor accessibility - limited feasibility for handling and transfers - process design flexible - accessibility not limited - process design can be adapted to different requirements Isolator Technology is limited suited for flexible processes with manual handling => pro Cleanroom 36

Isolator Technology vs Conventional Cleanroom Experiences gathered during Manufacturing Economic Efficiency Isolator Technology Cleanroom Technology Result Mechanical trouble leads to termination of processes More flexibility regarding troubleshooting Risk of losing batches is lower in a conv. cleanroom => pro Cleanroom Reduction of costs for environmental monitoring and gowning possible High costs for energy, environmental monitoring and gowning Reduced costs for maintaining Class 100 => Isolator Operating in three shifts is possible Daily disinfection and recovery time is required. Increased overall time for operations => Isolator 37

Isolator Technology vs Conventional Cleanroom Lessons Learned Efficiency 1. Changeover / Conversion: Sterile Core Area: Isolator: Changeover, test-run, disinfection Sum: 3 h to 4 h 7 h VHP sterilization + venting to limit 1 ppm 7.5 h cleaning + change over + test-run Sum: 15.50 h 2. Termination of Manufacturing Process: Isolator 2003: ca. 2.5 % Sterile Core Area : 0 Isolator 2004: ca. 1.5 % Sterile Core Area : 0 Isolator 2005: ca. 1.2 % Sterile Core Area : 0 38

Summary after five years experience with Isolator Technology designed and build for the supply of the world wide market with cytostatics Would we choose Isolator Technology again? Yes regarding maximum achievable product quality Yes regarding operator safety (EHS) Yes regarding process complexity and process stability Yes regarding economic efficiency Is the isolator basically the best concept for aseptic processing? Not always... but more and more! http://www.baxterbiopharmasolutions.com/contract_manufacturing/facilities_equipment/halle_germany.html 39